CytomX Therapeutics Inc (NASDAQ:CTMX)’s traded shares stood at 0.51 million during the last session, with the company’s beta value hitting 1.07. At the close of trading, the stock’s price was $1.67, to imply a decrease of -3.47% or -$0.06 in intraday trading. The CTMX share’s 52-week high remains $2.86, putting it -71.26% down since that peak but still an impressive 37.72% since price per share fell to its 52-week low of $1.04. The company has a valuation of $113.09M, with an average of 920.23K shares over the past 3 months.
CytomX Therapeutics Inc (NASDAQ:CTMX) trade information
After registering a -3.47% downside in the last session, CytomX Therapeutics Inc (CTMX) has traded red over the past five days. The stock hit a weekly high of 2.1400, dropping -3.47% in its intraday price action. The 5-day price performance for the stock is -22.33%, and -26.43% over 30 days. With these gigs, the year-to-date price performance is 7.74%.
CytomX Therapeutics Inc (CTMX) estimates and forecasts
Looking at statistics comparing CytomX Therapeutics Inc share performance against respective industry, we note that the company has underperformed competitors. CytomX Therapeutics Inc (CTMX) shares are 24.63% up over the last 6 months, with its year-to-date growth rate lower than industry average at -2,000.00% against 13.30%.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 67.21% for the past 5-year period. While 2024 is set for a -3067.00% return in earnings, projections for the next 5 years are at -0.90% annually.
CTMX Dividends
CytomX Therapeutics Inc has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. CytomX Therapeutics Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
